×
About 638 results

ALLMedicine™ Activated Clotting Time Center

Research & Reviews  225 results

Differences in activated clotting time and total unfractionated heparin dose during pul...
https://doi.org/10.1002/clc.23681
Clinical Cardiology; Zeljkovic I, Brusich S et. al.

Jul 2nd, 2021 - Periprocedural pulmonary vein isolation (PVI) anticoagulation requires balancing between bleeding and thromboembolic risk. Intraprocedural anticoagulation is monitored by activated clotting time (ACT) with target value >300 s, and there are no gui...

The Standard Point-of-Care Hemochron Jr. ACT+ Test in Monitoring Heparin Administration...
https://doi.org/10.1053/j.jvca.2021.05.021
Journal of Cardiothoracic and Vascular Anesthesia; Erkinaro T, Moilanen J et. al.

Jun 17th, 2021 - Coagulation factor XII (FXII) is a plasma serine protease that belongs to the contact activation complex responsible for initiating the intrinsic coagulation pathway. FXII deficiency is a rare congenital disorder that is not associated with an inc...

Efficacy of thromboelastography in the management of anticoagulation for veno-venous ex...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202565
Medicine Nakashima R, Nishihara M et. al.

Jun 12th, 2021 - In coronavirus disease 2019 (COVID-19) patients with acute respiratory distress syndrome refractory to optimal conventional management, we should consider the indication for veno-venous extracorporeal membrane oxygenation (V-V ECMO). Growing evide...

Evaluation of a Multimodal Heparin Laboratory Monitoring Protocol in Adult Extracorpore...
https://doi.org/10.1177/08971900211021249
Journal of Pharmacy Practice; Northam KA, Nguyen B et. al.

Jun 11th, 2021 - Anticoagulation monitoring practices vary during extracorporeal membrane oxygenation (ECMO). The Extracorporeal Life Support Organization describes that a multimodal approach is needed to overcome assay limitations and minimize complications. Comp...

Simple periprocedural precautions to reduce Doppler microembolic signals during AF abla...
https://doi.org/10.1007/s10840-021-01010-1 10.1111/j.1540-8167.2011.02050.x 10.1161/01.STR.0000173399.20127.b3 10.1111/j.1540-8167.2012.02420.x 10.1161/CIRCULATIONAHA.112.092544 10.1016/j.ejcts.2009.05.004 10.1111/j.1540-8167.2009.01509.x 10.1002/jum.14447 10.1016/j.jacep.2017.11.003 10.1371/journal.pone.0157886 10.1161/01.STR.0000022809.46400.4B
Journal of Interventional Cardiac Electrophysiology : an ... Christoph M, Poitz D et. al.

Jun 2nd, 2021 - Doppler microembolic signals (MES) occur during atrial fibrillation ablation despite of permanent flushed transseptal sheaths, frequent controls of periprocedural coagulation status and the use of irrigated ablation catheters PURPOSE: To investiga...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  16 results

Thrombin Generation During Cardiopulmonary Bypass With Titrated Versus Conventional Anticoagulation Management.
https://clinicaltrials.gov/ct2/show/NCT03347201

Dec 16th, 2019 - Cardiopulmonary bypass (CPB) allows cardiac surgery to be performed on a motionless, bloodless heart while maintaining circulation to the rest of the body. Anticoagulation with heparin prevents the body's clotting system from being activated when ...

Venovenous CO2 Removal (VVCO2R) in Patients With COPD and Acute Respiratory Failure
https://clinicaltrials.gov/ct2/show/NCT00594009

Mar 12th, 2019 - This is a pilot study to examine the efficacy and safety of an extracorporeal circuit to remove carbon dioxide (CO2) from the blood in patients with an acute exacerbation of COPD resulting in acute or acute on chronic respiratory failure. The extr...

Cerebral-tissue Oxygen Balance Affected by Diabetes Mellitus
https://clinicaltrials.gov/ct2/show/NCT03668301

Sep 24th, 2018 - One hour before the surgery, patients are premedicated with lorazepam (per os, 2.5 mg). Before induction of anesthesia, the NIRS sensors (INVOS 3100, Somanetics, MI, USA) arepositioned on both sides of the forehead. Sensors to detect depth of anes...

Evaluation of the Interference of Antithrombotic Agents With Laboratory Monitoring of Heparin Therapy
https://clinicaltrials.gov/ct2/show/NCT02839434

Sep 18th, 2018 - Oral anticoagulants are increasingly prescribed and the are not discontinued for invasive cardiac procedures . Additional parenteral anticoagulation is necessary for these procedures (FA ablation and invasive coronary explorations). The unfraction...

Evaluation of a New Sonoclot Device for Heparin Management in Cardiac Surgery
https://clinicaltrials.gov/ct2/show/NCT02588976

May 4th, 2018 - The SONOCLOT Analyzer (S1; Sienco, Inc. Boulder, CO USA, Model DP-2951) is used to routinely perform kaolin-based activated clotting time (kACT) as monitor of heparin therapy in patients undergoing cardiac operations on cardiopulmonary bypass. Apa...

see more →

News  12 results

Heparin Dosing Oddities in the Cath Lab: A 'Red Flag' Raises Questions
https://www.medscape.com/viewarticle/918035

Sep 10th, 2019 - The peculiar heparin behavior started about 6 months ago. Dosing that had been reliable countless times in the cath lab was failing to get the activated clotting time (ACT) to target, forcing extra boluses. "I called my pharmacy and asked them to ...

Heparin Dosing Oddities in the Cath Lab: A 'Red Flag' Raises Questions
https://www.staging.medscape.com/viewarticle/918035

Sep 10th, 2019 - The peculiar heparin behavior started about 6 months ago. Dosing that had been reliable countless times in the cath lab was failing to get the activated clotting time (ACT) to target, forcing extra boluses. "I called my pharmacy and asked them to ...

BRAVO 3: Bivalirudin No Better Than Heparin in TAVR
https://www.staging.medscape.com/viewarticle/852748

Oct 15th, 2015 - SAN FRANCISCO, CA — For patients undergoing transcatheter aortic-valve replacement (TAVR) via the femoral artery, the use of bivalirudin (Angiomax, the Medicines Company) did not significantly reduce the risk of bleeding, nor did it use reduce the...

Dosing the New Oral Anticoagulants in Atrial Fib: Can We Do Better?
https://www.medscape.com/viewarticle/829331

Aug 4th, 2014 - NEW YORK, NY — "Oral administration, please, but no cumbersome dosing strategies" could have been the tag line of the research community that spent decades looking for a more user-friendly alternative that is at least comparable to warfarin in eff...

Cardio Notes: Catheter Fix Cuts Leg Loss.
https://www.medpagetoday.com/cardiology/peripheralarterydisease/39580

Jun 3rd, 2013 - As surgeons use more minimally-invasive approaches to treat peripheral arterial disease, fewer patients need amputations. Also, testing dabigatran's therapeutic level, and the future cost of treating aortic stenosis. Lower Limb Amputations Down Ov...

see more →